Thiopeptide antibiotics: retrospective and recent advances.
Thiopeptides, or thiazolyl peptides, are a relatively new family of antibiotics that already counts with more than one hundred different entities. Although they are mainly isolated from soil bacteria, during the last decade, new members have been isolated from marine samples. Far from being limited to their innate antibacterial activity, thiopeptides have been found to possess a wide range of biological properties, including anticancer, antiplasmodial, immunosuppressive, etc. In spite of their ribosomal origin, these highly posttranslationally processed peptides have posed a fascinating synthetic challenge, prompting the development of various methodologies and strategies. Regardless of their limited solubility, intensive investigations are bringing thiopeptide derivatives closer to the clinic, where they are likely to show their veritable therapeutic potential.
Institute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.
Xavier
X
Just-Baringo
Institute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain. albericio@irbbarcelona.org.
Fernando
F
Albericio
Institute for Research in Biomedicine, Barcelona Science Park-University of Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain. mercedes.alvarez@irbbarcelona.org.
Mercedes
M
Álvarez
D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D004345:Drug Industry; D006801:Humans; D008386:Marine Biology; D008826:Microbial Sensitivity Tests; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology*; D011485:Protein Binding; D011487:Protein Conformation; D019155:Veterinary Drugs
D000900:Anti-Bacterial Agents; D010455:Peptides; D019155:Veterinary Drugs